KEYTRUDA 25 mg/mL concentrate for solution for infusion, Acasunlimab
GCT1046-04
Phase 2 small_molecule active
Quick answer
KEYTRUDA 25 mg/mL concentrate for solution for infusion, Acasunlimab for Malignant Solid Tumors - Non Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Genmab A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genmab A/S
- Indication
- Malignant Solid Tumors - Non Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active